Status:
COMPLETED
Impact of Steroids on Inflammatory Response in Covid-19
Lead Sponsor:
Assiut University
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
we designed this study to observe the efficacy and safety of dexamethasone versus methylprednisolone in covid-19 diseased patients upon monitoring the inflammatory response and to compare the outcome ...
Detailed Description
A written informed consent will be taken from the patients or their relatives. The study will involve adults (age 18-no limit years) who will be diagnosed covid-19 with destructive inflammatory immune...
Eligibility Criteria
Inclusion
- Adults (age 18-no limit years) who will be diagnosed covid-19
- With destructive inflammatory immune response needing ICU admission to be run on steroid therapy.
Exclusion
- Severe immunosuppression like HIV (Human immunodeficiency Virus)
- Long term use of immunosuppressant for any other chronic illness
- Pregnant or lactating females
- Patients who are on chronic use of corticosteroids like asthma, rheumatoid arthritis.
Key Trial Info
Start Date :
May 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04909918
Start Date
May 28 2021
End Date
August 20 2021
Last Update
September 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospital
Asyut, Assuit, Egypt, Assuit universi